Jushi Holdings Inc. Reports Second Quarter 2026 Financial Results
Jushi Holdings Inc. reported Q2 2026 results for the quarter ended June 30, 2026. Revenue rose 10% year over year to $71.3 million, with wholesale revenue up 68% to $9.4 million. Net loss was $7.3 million and adjusted EBITDA was $13.3 million. Jushi cited a $6.4 million discrete tax benefit from medical marijuana rescheduling and record Virginia revenue.
How this was made
The 30-second read
Why it matters
The key tradable elements are (1) Q2 financials with record wholesale revenue, (2) a discrete $6.4M income tax benefit linked to federal rescheduling and elimination of Section 280E for qualifying activities, and (3) Virginia adult-use market legislation with sales starting July 1, 2027.
Market read
Traders can reassess near-term earnings quality and regulatory tailwinds from rescheduling, while also pricing the longer-dated Virginia adult-use ramp.
What to watch
Net loss widened versus adjusted EBITDA (net loss still -$7.3M) and the article provides limited cash-flow and financing detail, so liquidity and dilution risk could dominate the stock’s next move.
Background
Jushi is a vertically integrated, multi-state cannabis operator; this release covers Q2 2026 ended June 30, 2026 and includes regulatory and state-market developments.
Ticker impact
Jushi reported Q2 2026 results, including revenue up 10% to $71.3M and a $6.4M discrete tax benefit tied to federal rescheduling.
Near-term bias upward versus prior expectations, with follow-through dependent on whether adult-use transition in Virginia drives sustained margin and cash flow.
The article discloses fresh GAAP and non-GAAP figures plus a specific $6.4M discrete tax benefit and wholesale growth record. However, it does not provide guidance or balance-sheet/cash-flow detail beyond quarter-end cash, limiting conviction on forward earnings power.
Market effects
Highlights how federal rescheduling can reduce 280E-related tax drag for state-licensed medical operators, potentially improving sector earnings quality.
Virginia adult-use legislation creates a dated catalyst (July 1, 2027) for operators with cultivation and retail infrastructure in the state.
Limited direct global impact; primarily a US cannabis regulatory and state-market execution story.
Counterpoint
Wholesale growth and the tax benefit may not translate into durable profitability if pricing pressure persists and adjusted EBITDA remains roughly flat year-over-year.
Key entities
- companyJushi Holdings Inc.
Reported Q2 2026 revenue growth, record wholesale revenue, and a $6.4M discrete tax benefit tied to federal rescheduling.